Trial Profile
Randomized controlled trial evaluating the effect of a GNRH-antagonist in women with PCOS undergoing ovulation induction with gonadotropins and intrauterine insemination
Status:
Not stated
Phase of Trial:
Phase III
Latest Information Update: 20 Oct 2009
Price :
$35
*
At a glance
- Drugs Follitropin beta (Primary) ; Ganirelix
- Indications Female infertility
- Focus Therapeutic Use
- 21 Oct 2009 Primary endpoint 'Clinical pregnancy rate' has not been met.
- 21 Oct 2009 Interim results were reported at the 65th Annual Meeting of the American Society for Reproductive Medicine.
- 20 Oct 2009 New trial record.